Dr Isabel Pappworth
| Selectivity of C3-opsonin targeted complement inhibitors: a distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients | 2016 |
|
Dr Edwin Wong
Professor Neil Sheerin
Dr Isabel Pappworth
| An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy | 2015 |
|
Rachael Watson
Dr Karim Bennaceur
Catriona Barker
Professor David Kavanagh
Professor Tim Goodship
et al. | Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS) | 2015 |
|
Dr Edwin Wong
Dr Jeremy Palmer
Professor Neil Sheerin
Dr Isabel Pappworth
| FH1-5(18-20) ameliorates experimental C3 glomerulopathy; generation and testing of a murine version for further pre-clinical experiments | 2015 |
|
Dr Edwin Wong
Dr Isabel Pappworth
Professor Claire Harris
Professor Tim Goodship
Dr Sally Johnson
et al. | The national study of membranoproliferative glomerulonephrtis and C3 glomerulopathy - characterisation of the paediatric cohort | 2015 |
|
Catriona Barker
Professor David Kavanagh
Professor Tim Goodship
Dr Isabel Pappworth
| Autoantibodies to CD59, CD55, CD46 and CD35 are not associated with aHUS | 2014 |
|
Professor Tim Goodship
Dr Isabel Pappworth
Dr Iain Moore
Dr Eva-Maria Hunze
James Staniforth
et al. | Factor H autoantibodies in membranoproliferative glomerulonephritis | 2012 |
|
Professor David Kavanagh
Dr Isabel Pappworth
Christine Hayes
Dr Iain Moore
Dr Eva-Maria Hunze
et al. | Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome: Disease-Associated or an Epiphenomenon? | 2012 |
|
Dr Iain Moore
Dr Lisa Turnbull
Dr Isabel Pappworth
Professor David Kavanagh
James Staniforth
et al. | Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome | 2010 |
|
Dr Isabel Pappworth
Dr Iain Moore
Dr Lisa Turnbull
Professor David Kavanagh
James Staniforth
et al. | Complement Factor H Autoantibodies and Age-Related Macular Degeneration | 2010 |
|
